Ketamine administration during waking increases delta EEG intensity in rat sleep

Area of Science:

• Neuroscience
• Sleep Science
• Pharmacology

Background:

• The homeostatic model of sleep posits that increased waking metabolic activity in neuronal systems enhances subsequent sleep intensity.
• Ketamine is known to increase the metabolic rate of limbic brain structures.

Purpose of the Study:

• To test the hypothesis that increased waking metabolic rate enhances delta electroencephalographic (EEG) intensity during nonrapid-eye-movement (NREM) sleep.
• To investigate the effects of ketamine on sleep parameters.

Main Methods:

• Sprague-Dawley rats received intraperitoneal injections of ketamine (15, 25, or 50 mg/kg) or saline.
• Injections were administered three times during the dark (waking) period, with the last dose 4-5 hours before the light (sleep) period.
• Delta EEG intensity and NREM duration were measured.

Main Results:

• Ketamine administration led to significant increases in both NREM sleep duration and delta EEG intensity (amplitude and incidence) compared to saline controls.
• The observed increase in delta sleep intensity was substantial, among the largest pharmacologically induced stimulations reported.
• Ketamine induced widespread metabolic changes and acts on multiple receptor classes.

Conclusions:

• The findings support the homeostatic model of sleep by demonstrating a link between increased waking brain metabolism and enhanced delta sleep intensity.
• Excitatory amino acid receptor systems, particularly N-methyl-D-aspartate (NMDA) receptors, are implicated in sleep regulation.
• Ketamine's effects on sleep provide insights into the neurobiological mechanisms of sleep regulation.